Actively Recruiting

Age: 18Years +
All Genders
NCT04668872

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-03-12

80

Participants Needed

1

Research Sites

313 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to study the way radioembolization works by collecting biopsy samples of participants' tumors after the procedure. This research may improve the way that radioembolization is performed, which could help people whose cancer has spread to the liver. The research may also provide information about how tumors respond to radioembolization.

CONDITIONS

Official Title

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • Histologically confirmed primary adenocarcinoma of the colon or rectum
  • Liver metastases considered unresectable or not suitable for percutaneous ablation
  • Existing biopsy tissue samples from target tumor within 42 days prior to treatment or clinical indication for biopsy at treatment
  • Adequate blood cell counts (WBC > 1.5 x 10^9/L, platelet count > 50 x 10^9/L)
  • Adequate kidney function (creatinine < 1.5 mg/dL)
  • Total bilirubin level ≤ 1.5 mg/dL
  • For radiation segmentectomy: patients not eligible for surgery or thermal ablation
Not Eligible

You will not qualify if you...

  • Prior hepatic radiotherapy to the lesion or lobe being treated
  • Severe cirrhosis
  • Severe portal hypertension
  • Uncorrectable blood flow to gastrointestinal tract
  • Radiation absorbed dose to lungs >30 Gy (or >50 Gy in multiple sessions)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10065

Actively Recruiting

Loading map...

Research Team

C

Constantinos T Sofocleous, MD, PhD

CONTACT

A

Assen Kirov, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation | DecenTrialz